Navigation Links
Helix BioPharma announces Q1 2008 financial results
Date:12/17/2007

ment collaborations, and other strategic alliances, which, if obtained, may reduce the Company's interest in its projects or products. There can be no assurance, however, that any alternative sources of funding will be available.

The Company's unaudited interim consolidated first quarter fiscal 2007 and 2006 financial statements are summarized below:

-------------------------------------------------------------------------

Consolidated Statements of Operations

for the three month period ended October 31

(thousand $, except for per share data)

2007 2006

---------------------------

Revenue:

Product revenue 754 696

License fees and royalties 131 130

Research and development contracts - -

---------------------------

885 826

Expenses:

Cost of sales 313 290

Research and development 782 871

Operating, general and admin 1,313 906

Amortization of intangibles 7 40

Amortization of capital assets 66 77

Stock-based compensation 12 12

Interest income, net (104) (102)

Foreign exchange loss 108 45

---------------------------

2,497 2,139

Loss before income taxes
'/>"/>

SOURCE Helix BioPharma Corp.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11

Related biology technology :

1. Helix Biopharma announces addition of University of Arizona professor Kenneth Hatch as new medical advisor
2. Helix BioPharma Chairman resigns
3. Helix BioPharma Corp. announces fiscal 2007 results
4. Helix BioPharma Corp. announces management changes
5. Helix BioPharma announces $16.9 million private placement of common shares
6. China Biopharmaceuticals Holdings Announces Second Quarter 2007 Financial Results
7. XTL Biopharmaceuticals Announces Financial Results for the Six Months Ended June 30, 2007
8. PDL BioPharma Announces Internal CEO Investigation Found No Credible Evidence of Improper Personal Conduct or Breach of Fiduciary Duty
9. Nabi Biopharmaceuticals to Present at Upcoming Industry Conferences
10. PDL BioPharma Announces Significant Strategic and Portfolio Changes to Focus on Antibody Discovery and Development
11. XTL Biopharmaceuticals Announces Presentation of Novel Pre-Clinical Inhibitors of Hepatitis C at an Upcoming International Scientific Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/20/2014)... Convey Computer , the leader in hybrid-core ... University won first place in the 2014 MemoCODE ... team’s solution achieved the highest overall performance in the ... finisher. , Experts from all segments of the commercial ... using a variety of design tools, hardware and software. ...
(Date:10/20/2014)... PureTech , a science and technology development ... today the closing of a $55 million growth ... a $120 Billion group of funds. The funding ... forward and to advance new healthcare related products ... really go for the big ideas that can ...
(Date:10/19/2014)... 2014 OCTOBER 20-22, 2014: ... ABIM will take place at the ... ABIM 2014 is now available at ... companies and organizations from all over the ... on the latest products and developments on ...
(Date:10/19/2014)... 2014 The report "Chocolate, Cocoa Beans, ... Prices, Geography Trend and Forecast (2011 - 2016)," ... geography and studies the major market drivers, restraints, and ... and Asia. , The global chocolate market is expected ... in 2016 at an estimated CAGR of 2.7% from ...
Breaking Biology Technology:Team from Iowa State Wins 2014 MemoCODE Design Contest Using Convey HC-2ex 2Team from Iowa State Wins 2014 MemoCODE Design Contest Using Convey HC-2ex 3PureTech Announces Expansion with Oversubscribed $55M Funding Round 2PureTech Announces Expansion with Oversubscribed $55M Funding Round 3PureTech Announces Expansion with Oversubscribed $55M Funding Round 4PureTech Announces Expansion with Oversubscribed $55M Funding Round 5PureTech Announces Expansion with Oversubscribed $55M Funding Round 6Chocolate Market Projected To Reach $98.3 Billion by 2016 - New Report by MarketsandMarkets 2Chocolate Market Projected To Reach $98.3 Billion by 2016 - New Report by MarketsandMarkets 3Chocolate Market Projected To Reach $98.3 Billion by 2016 - New Report by MarketsandMarkets 4
... EAST NORRITON, Pa., Feb. 7, 2011 Tengion, Inc. (Nasdaq: ... announced that Steven Nichtberger, M.D., President and Chief Executive Officer ... CEO & Investor Conference on Monday, February 14, 2011, at ... panel discussion titled "IPO Window-Creaking Open or Wide Open?" the ...
... N.J., Feb. 7, 2011 ... today it will host a roundtable and give a ... week at the Summit for Clinical Ops Executives ( ... hotel. (Logo: http://photos.prnewswire.com/prnh/20100707/NY31446LOGO) As part ...
... of California, Berkeley, have found a way to grow nanolasers ... to a new class of faster, more efficient microprocessors, as ... They describe their work in a paper ... of the journal Nature Photonics . "Our ...
Cached Biology Technology:Tengion to Present at the 13th Annual BIO CEO & Investor Conference and the Leerink Swann 'Hot Topics in Therapeutics' Roundtable Conference 2Cmed Technology to Host Roundtable, Give Presentation About EDC Pain Points at Summit for Clinical Ops Executives (SCOPE) 2Cmed Technology to Host Roundtable, Give Presentation About EDC Pain Points at Summit for Clinical Ops Executives (SCOPE) 3Engineers grow nanolasers on silicon, pave way for on-chip photonics 2Engineers grow nanolasers on silicon, pave way for on-chip photonics 3
(Date:10/16/2014)... Conn. , October 16, 2014 NXT-ID, ... or the "Company"), a biometric authentication company focused on ... its leading edge technologies including Wocket™, the Smart Wallet, ... (FiRe) Conferenece. FiRe is a leading global conference on ... Hosted by Mark Anderson , founder and ...
(Date:10/15/2014)... ability to assess the pandemic risk from strains of ... must not allow ourselves to become complacent that the ... consortium of scientists. , Influenza pandemics arise when a ... to develop widespread immunity – spreads in the human ... past 100 years, the worst of which – the ...
(Date:10/15/2014)... admitted Johannes Gutenberg University Mainz (JGU) as a ... continues to maintain a significant nationwide standing in ... acceptance of Johannes Gutenberg University Mainz as a ... in the national and international competition for the ... Rhineland-Palatinate can be proud that Mainz University has ...
Breaking Biology News(10 mins):NXT-ID Inc. to Present at 13th Annual FiRe Conference 2NXT-ID Inc. to Present at 13th Annual FiRe Conference 3Scientists 'must not become complacent' when assessing pandemic threat from flu viruses 2Johannes Gutenberg University Mainz joins Germany's Gauss-Allianz as a full member 2Johannes Gutenberg University Mainz joins Germany's Gauss-Allianz as a full member 3
... Sunday, March 10, 2013, Cleveland: Researchers from Cleveland Clinic ... commonly used drug to treat anemia in heart failure ... nor does it reduce their risk of death from ... presented at the American College of Cardiology,s annual meeting ...
... in German . , Protein activity ... lead to uncontrolled growth and thus cancer or chronic ... Molecular Biology from the University of Zurich have identified ... proteins. Their discovery enables these proteins to be manipulated ...
... researchers have been using atomic force microscopy (AFM) to ... AFM-based measurements of chemistry and chemical properties of materials ... the University of Illinois at Urbana-Champaign report that they ... small as 15 nm, using a novel technique called ...
Cached Biology News:Cleveland Clinic research shows anemia drug does not improve health of anemic heart failure patients 2Selectively manipulating protein modifications 2University of Illinois researchers develop AFM-IR for nanometer scale chemical identification 2
... Anti-Major DNA-binding protein(DBP). Protein ... NP_001343 ELISA titre using ... Suggested conditions for Western Blot: ... buffer, and HRP conjugated anti-Rabbit IgG should ...
Collected from sexually mature, mixed sex, mixed breed guinea pigs. Pricing: $120/unit for 1 - 10 units...
SEQUENASE PCR PRODUCT PRE-SEQU, 1 EA. Category: SEQUENASE....
Mouse monoclonal [IFR0104] to Salmonella enteriditis ( Abpromise for all tested applications)....
Biology Products: